Implantable microdevices to measure drug responses and identify optimal treatments in
cancer patients

Dr. Jonas has developed an implantable microdevice platform that measures therapeutic responses directly within living human tumors through localized microdosing. By integrating spatial pathology, multiplex imaging, transcriptomics, and other multimodal analyses, his platform accelerates translational cancer research, enables patient-specific therapeutic profiling, and generates largescale human datasets to advance precision oncology and drug discovery.